In silicoScreening of Chemical Libraries to Develop Inhibitors That Hamper the Interaction of PCSK9 with the LDL Receptor-Reference-Cited by-同舟云学术

In silicoScreening of Chemical Libraries to Develop Inhibitors That Hamper the Interaction of PCSK9 with the LDL Receptor

Published:2015 Issue:5 Volume:56 Page:1251
ISSN:0513-5796
Container-title:Yonsei Medical Journal
language:en
Short-container-title:Yonsei Med J

Author:

Min Dong-Kook¹²,Lee Hyun-Sook¹,Lee Narae¹²,Lee Chan Joo¹²,Song Hyun Joo¹,Yang Ga Eul¹,Yoon Dojun³,Park Sahng Wook¹²

Affiliation:

1. Department of Biochemistry and Molecular Biology, Institute of Genetic Science, Integrated Genomic Research Center for Metabolic Regulation, Yonsei University College of Medicine, Seoul, Korea.

2. Brain Korea 21 PLUS Project for Medical Science, Yonsei University College of Medicine, Seoul, Korea.

3. Department of Biochemistry, Catholic Kwandong University College of Medicine, Gangneung, Korea.

Funder

National Research Foundation of Korea

Yonsei University College of Medicine

Publisher

Yonsei University College of Medicine

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3349/ymj.2015.56.5.1251

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis;Acta Pharmacologica Sinica;2024-05-29

2. The Causal Relationship between PCSK9 Inhibitors and Osteoporosis Based on Drug-Targeted Mendelian Combined Mediation Analysis;Calcified Tissue International;2024-05-24

3. Discovery of (2‐(4‐Substituted phenyl)quinolin‐4‐yl)(4‐isopropylpiperazin‐1‐yl)methanone Derivatives as Potent Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors;ChemMedChem;2023-12-13

4. New Biological Therapies for Low-Density Lipoprotein Cholesterol;Canadian Journal of Cardiology;2023-12

5. The Link between miRNAs and PCKS9 in Atherosclerosis;Current Medicinal Chemistry;2023-11-16